Overall, since PTP1B and TCPTP can act coordinately to regulate diverse biological pathways, dual agents targeted to both these PTPs might be useful for therapeutic intervention in different diseases, particularly as novel agents capable of enhancing the anticancer actions of immune cells and inhibiting tumor progression. This evidence concerns the gene PTPN1 and neoplasm.